Taxim Injection 250 mg/5 ml contains Cefotaxime, a third-generation cephalosporin antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria. It is used to treat moderate to severe bacterial infections in adults and children, particularly those caused by susceptible pathogens.

Cefotaxime works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Taxim Injection 250 mg/5 ml is suitable for intravenous (IV) or intramuscular (IM) administration, allowing rapid therapeutic concentrations in the bloodstream. Its enhanced stability against beta-lactamases makes it effective against bacteria resistant to earlier-generation cephalosporins.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Taxim Injection 250 mg/5 ml is indicated for:

• Respiratory tract infections, including pneumonia and bronchitis

• Urinary tract infections, including complicated UTIs

• Skin and soft tissue infections

• Bone and joint infections

• Septicemia and bacteremia caused by susceptible organisms

• Meningitis in appropriate cases

• Empiric therapy for serious infections where multi-drug resistant pathogens are suspected

It is particularly useful in pediatric patients or adults requiring moderate doses for mild to moderate infections, offering flexibility in dosing.

Mechanism of Action

Cefotaxime, the active ingredient in Taxim Injection, is a beta-lactam antibiotic. Its mechanism includes:

• Inhibition of bacterial cell wall synthesis: Binds to penicillin-binding proteins (PBPs), preventing proper cross-linking of peptidoglycan layers

• Bactericidal activity: Leads to bacterial lysis and death

• Broad-spectrum efficacy: Effective against many Gram-positive and Gram-negative bacteria, including E. coli, Klebsiella, Proteus, and some strains of Pseudomonas

• Stability against beta-lactamases: Allows activity against bacteria resistant to first- and second-generation cephalosporins

This mechanism makes Taxim Injection a reliable option for treating a variety of bacterial infections.

Dosage and Administration

• Adults: Typically 250 mg to 1 g every 8 to 12 hours, depending on severity and infection type.

• Pediatrics: Dose is calculated based on body weight, usually 50–100 mg/kg/day divided into 2–4 doses.

• Administer intravenously (IV) slowly or intramuscularly (IM) after reconstitution with sterile water or a suitable diluent.

• Dose adjustments are required in patients with renal impairment.

• The solution should be prepared under sterile conditions and used immediately or stored according to manufacturer instructions.

Precautions and Warnings

• Avoid use in patients with known hypersensitivity to cephalosporins or penicillins, due to potential cross-reactivity.

• Monitor renal and hepatic function during prolonged therapy.

• Use with caution in patients with history of gastrointestinal disease, as antibiotics can predispose to Clostridium difficile-associated diarrhea.

• Inform the healthcare provider of all concurrent medications to prevent drug interactions, including aminoglycosides or anticoagulants.

Side Effects

Taxim Injection 250 mg/5 ml is generally well tolerated. Common side effects include:

• Pain or irritation at the injection site

• Mild gastrointestinal discomfort (nausea, diarrhea)

• Headache or dizziness

• Rare but serious effects: allergic reactions, hematologic abnormalities, nephrotoxicity, or superinfections

Seek immediate medical attention if severe allergic reactions, persistent diarrhea, or signs of infection occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store below 30°C in a cool, dry place, away from light. Keep the vial tightly closed and out of reach of children. Reconstituted solutions should be used immediately or stored according to manufacturer guidelines.

Taxim Injection 250 mg/5 ml provides effective broad-spectrum antibacterial therapy, particularly suitable for moderate infections in adults and children, ensuring rapid relief and optimal bacterial control under medical supervision.